作者:Deng Deming
院校:Hebei Medical University, Hebei Shijiazhuang, 050017
Non-alcoholic fatty liver disease; Gas chromatography - mass spectrometry; Serum metabolomics; Disease severity; Biomarkers
[1] Gitto, S., Federico, A., & Gambino, R. (2018). Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives. Metabolites, 8(2), 30.
[2] Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016). Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73–84.
[3] Fatty Liver and Alcoholic Liver Disease Group, Chinese Society of Hepatology, Chinese Medical Association; Expert Committee on Fatty Liver Disease, Chinese Medical Doctor Association. (2018). Guidelines for the prevention and treatment of non-alcoholic fatty liver disease (updated version in 2018). Chinese Journal of Hepatology, 26(3), 195–203.
[4] Valenti, L., Alisi, A., & Nobili, V. (2019). Pharmacological treatment of non-alcoholic fatty liver disease: an update. Expert Opinion on Pharmacotherapy, 20(18), 2183–2193.
上一个:The application research on the Automatic Detection and Grading of Microaneurysms in Fundus Images of Diabetic Retinopathy by Artificial Intelligence Deep Learning Algorithms
下一个:The impact of artificial intelligence-assisted intensity-modulated radiotherapy plan optimization on the radiation doses received by the rectum and bladder as well as radiation-induced injuries in patients with locally advanced cervical cancer
返回列表
Copyright © 2021-2022 未来科学出版社 All Rights Reserved.
+65 6396 6190
微信二维码